Carcinoma: all 6,719 studies
Page 5 of 68. Open to participants first (1,142), then studies with results posted, then the rest; newest registration first within each.
- Neoadjuvant Targeted Therapy in Patients With Resectable EGFR-mutated Lung Squamous Cell CarcinomaRecruitingNCT06383728Phase 2
- A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid TumorsNot yet recruitingNCT06383507Phase 1
- Biomarkers and Molecular Mechanism Study of Hepatocellular Carcinoma After Radical Resection and Conversion TherapyRecruitingNCT06382103
- A Phase I/II Trial of UCB4594 in Participants With Advanced CancerRecruitingNCT06380816Phase 1/2
- Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and OutcomeRecruitingNCT06380686
- BAI-BACE for Advanced Lung Squamous Cell CarcinomaRecruitingNCT06377735Not applicable
- Ivonescimab Combined With HAIC for the Treatment of Unresectable Hepatocellular Carcinoma（uHCC）.RecruitingNCT06375486Phase 2
- HAIC Combined With PD-L1 Plus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma After Immunotherapy FailureNot yet recruitingNCT06375317Phase 2
- Study of ZG005 in Combination With Etoposide and Cisplatin in Participants With Advanced Neuroendocrine Carcinoma.RecruitingNCT06372626Phase 1/2
- A Study of AK104+Lenvatinib in Combination With Transarterial Chemoembolization (TACE) Versus TACE in Participants With Incurable/Non-metastatic Hepatocellular CarcinomaRecruitingNCT06371157Phase 3
- Serplulimab Combined With Bevacizumab Biosimilar and HAIC in Advanced Hepatocellular Carcinoma (HCC) PatientsRecruitingNCT06370065Phase 2
- KSD-101 Therapy for Standard Treatment Failed EBV-associated NPC: an Exploratory Clinical TrialNot yet recruitingNCT06370026Early Phase 1
- Tirelizumab in Combination With Carboplatin and Polymeric Micellar Paclitaxel for Neoadjuvant Therapy in cN+ HNSCCNot yet recruitingNCT06366945Phase 2
- Study on the Efficacy and Safety of Conversion Therapy in Patients With Initially Unresectable Hepatocellular CarcinomaRecruitingNCT06365034
- Sintilimab Combination Therapy Plus IMRT in Nasopharyngeal CarcinomaNot yet recruitingNCT06364826Phase 2
- Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial of Hepatocellular Carcinoma Resistant to PD-1 Monoclonal AntibodyNot yet recruitingNCT06364800Early Phase 1
- Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial for First-line Treatment of Hepatocellular CarcinomaNot yet recruitingNCT06364787Phase 1
- CARE1 Pragmatic Clinical TrialRecruitingNCT06364631Phase 3
- HAIC Combined With Durvalumab and Tremelimumab and Lenvatinib in uHCCRecruitingNCT06364007Phase 2
- A Study of TAE+HAIC Combined With Camrelizumab and Apatinib in the Treatment of Advanced Hepatocellular CarcinomaRecruitingNCT06363825Phase 2
- Combination of Cardonizumab Injection and TKI Second Line Therapy for Advanced Hepatocellular CancerRecruitingNCT06363006Phase 1
- Anti-PD-1/PD-L1 Combined With Anti-angiogenic Agents as First-line Treatment for Unresectable HCCRecruitingNCT06360042Phase 2
- Oropharynx (OPX) Biomarker TrialRecruitingNCT06356272
- Hepatocellular Carcinoma Liver OrganoidsRecruitingNCT06355700Not applicable
- A Study of Neoadjuvant Therapy for the Treatment of Patients With Locally Advanced Esophageal Squamous Cell CarcinomaRecruitingNCT06354530Phase 2/3
- DV Combined With Toripalimab for Renal Preservation in Solitary Kidney or Renal Insufficiency or Bilateral Multiple UTUCRecruitingNCT06354231Phase 2
- PPIO-008 Tislelizumab Combined With S-1 in Patients With ypT+N0 ESCC After Radical Resection With Neoadjuvant STUDYRecruitingNCT06354140Phase 2
- A Study to Explore the Reasonable Dosage and Evaluate the Efficacy, Safety and Tolerability of HLX10 and HLX04 with or Without HLX53 in Untreated, Locally Advanced or Metastatic Hepatocellular Carcinoma Patients.RecruitingNCT06349980Phase 2
- Adebrelimab and Chemoradiotherapy in High-risk LANPCRecruitingNCT06349889Phase 2
- A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies.RecruitingNCT06349044Not applicable
- To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell CarcinomaRecruitingNCT06344052Phase 2
- Dermatoscopy Guided Resection for Skin CancerRecruitingNCT06342297Not applicable
- European Active Surveillance of Renal Cell Carcinoma Study (EASE RCC Study)RecruitingNCT06336187
- Multi-modal Characterisation of Hepatocellular Carcinoma (HCC) Treated with Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National CohortRecruitingNCT06334965Not applicable
- A Study of Nimotuzumab Plus Concurrent Chemoradiotherapy Sequential Maintenance Treatment for Cervical CarcinomaNot yet recruitingNCT06333821Phase 3
- HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular CarcinomaRecruitingNCT06333561
- Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal CarcinomaNot yet recruitingNCT06331845Phase 2
- Impact of "No-touch" Technique on the Outcome of Liver Transplantation for Hepatocellular CarcinomaNot yet recruitingNCT06331273
- Assessment of AFP and PIVKA-II as Prognostic Indicators in Liver Transplantation for Hepatocellular CarcinomaNot yet recruitingNCT06331260
- The Diagnostic Efficacy of Glutamine Synthetaseand BCLAF1in Early Diagosis of Hepatocellular Carcinoma in Cirrhotic PatientsNot yet recruitingNCT06328283
- Innovative Diagnosis and Therapy in LDLT Patients With High-risk Hepatocellular CarcinomaRecruitingNCT06327269Early Phase 1
- A Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug (ETN101) in Advanced Hepatocellular CarcinomaRecruitingNCT06326502Phase 1
- Tislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in Resectable Clinically Node-negative Head and Neck Squamous Cell CarcinomaRecruitingNCT06323369Phase 2
- Sequencing-based Counting of Plasma Epstein-Barr Virus DNA in Non-metastatic Nasopharyngeal CarcinomaRecruitingNCT06321939
- A Study of JMKX003948 Tablets in Patients With Renal Cell CarcinomaRecruitingNCT06321250Phase 1
- Value of Dynamic Monitoring of Early Recurrence of Hepatocellular Carcinoma After Radical Resection Based on CTCSNot yet recruitingNCT06317896
- De-escalated Radiotherapy for Primary Tumor After Neoadjuvant Therapy With Toripalimab Plus Chemotherapy for Nasopharyngeal CarcinomaRecruitingNCT06313450Not applicable
- Combination of SBRT and Immunotherapy in Small Hepatocellular Carcinoma (HSBRT2402)RecruitingNCT06313190Phase 2
- A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)RecruitingNCT06312137Phase 3
- Retrospective and Prospective Observational Study in Patients With Advanced Basal Cell CarcinomaRecruitingNCT06309836
- Neoadjuvant SBRT in Localized Advanced HNSCCRecruitingNCT06306846Phase 2
- Neoadjuvant Chemoradiotherapy Followed by Sequential Immunotherapy for Thoracic Esophageal Squamous Cell CarcinomaEnrolling by invitationNCT06303583Phase 1/2
- Artificial Intelligence Prediction Tool in Thymic Epithelial TumorsRecruitingNCT06301945
- Rituximab Combined With Prior Therapy in Advanced Hepatocellular Carcinoma: Efficacy & Safety StudyRecruitingNCT06301399Phase 2
- TPC Versus GP Induction Chemotherapy for Nasopharyngeal CarcinomaRecruitingNCT06301165Phase 2
- Modified TOMOX-HAIC in Combination With Sintilimab and Bevacizumab Biosimilar for First-line Treatment of Advanced Hepatocellular CarcinomaRecruitingNCT06285019Phase 2
- Xerostomia-optimised IMRT Versus Standard IMRT in NPCRecruitingNCT06282497Not applicable
- Treatment Pleural Carcinosis of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin AdministrationRecruitingNCT06281860Phase 1
- A Trial of Cadonilimab Plus Regorafenib in Patients With Hepatocellular Carcinoma Who Failed Camrelizumab Combined With ApatinibRecruitingNCT06280105Phase 2
- Upfront Immune Checkpoint Inhibitors With Deferred Cytoreductive Nephrectomy for Metastatic Renal Cell CarcinomaNot yet recruitingNCT06279403Phase 2
- A Comparative Study of the Treatment of Real-world Patients With Clear Cell Carcinoma of the OvaryRecruitingNCT06279104
- The Combination of Adebrelimab and TP Regimen for Neoadjuvant Therapy in Patients With Stage IVB Oral Squamous Cell CarcinomaRecruitingNCT06277791Phase 2
- Remote Assessment of OCT Scans for BCC DetectionNot yet recruitingNCT06273709
- Evaluation of AKR1B10 as a New Marker for Interventional Therapy of Hepatocellular CarcinomaRecruitingNCT06272656
- Evaluation of the Efficiency and Economic Impact of LC-OCT (Line-field Confocal Optical Coherence Tomography) for the Diagnosis and Management of Basal Cell CarcinomasNot yet recruitingNCT06271603Not applicable
- Stress-reducing Intervention in Urothelial CarcinomaRecruitingNCT06269536Not applicable
- The Protection of Thyroid Function in IMRT for Nasopharyngeal CarcinomaRecruitingNCT06268600Not applicable
- Cryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary MetastasesRecruitingNCT06265350Not applicable
- Active Surveillance for Low-risk Papillary Thyroid CarcinomaEnrolling by invitationNCT06261190
- Combination of SBRT, PD-L1 Inhibitor, and Lenvatinib in Hepatocellular Carcinoma (HSBRT2401)RecruitingNCT06261125Phase 2
- Anti-PD1 Monoclonal Antibody Combined With Nimotuzumab and Capecitabine in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal CarcinomaRecruitingNCT06259721Phase 2
- Surveillance of the Genetic Signature in Circulating Tumor DNA for Guiding Adjuvant Chemotherapy in Urothelial CarcinomaRecruitingNCT06257017Phase 2
- Efficacy and Safety of Intratumoral Injection of Recombinant Human Adenovirus Type 5 Combined With Tislelizumab and Lenvatinib in the Treatment of Advanced Hepatocellular CarcinomaNot yet recruitingNCT06253598Phase 2
- Accurate Diagnosis of the Invasion Depth in ESCC by a Deep Neural Network Analysis of NBI Endoscopy DataNot yet recruitingNCT06252974
- Real-world Evaluation of Diagnostic and Treatment Strategies in Low-Risk Basal Cell CarcinomaRecruitingNCT06252857
- AIOCC Italian Registry on Head and Neck CarcinomasRecruitingNCT06248944
- Surgical Resection Combined With Intraperitoneal Hyperthermic ChemotherapyNot yet recruitingNCT06247293
- Efficacy and Safety of SBRT Combined With Atezolizumab Plus Bevacizumab vs Atezolizumab Plus Bevacizumab in Treating Unresectable Advance Hepatocellular Carcinoma.Not yet recruitingNCT06244446
- HAIC (Hepatic Artery Infusion Chemotherapy，HAIC）Plus Sintilimab and Donafenib in the First-line Treatment of Unresectable Hepatocellular CarcinomaRecruitingNCT06244225Phase 2
- A Multi-center, Randomized, Double-blind, Phase II/III Clinical Trial of AK104 or Placebo in Combination With Chemotherapy as Second-line or More Lines for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)RecruitingNCT06241599Phase 2/3
- Immunotherapy for Hepatocellular CarcinomaRecruitingNCT06241326
- Study of ZG005 in Combination With Paclitaxel＋Platinum-based ± Bevacizumab in Patients With Advanced Cervical CarcinomaRecruitingNCT06241235Phase 1/2
- AI-Based Multimodal Multi-tasks Analysis Reveals Tumor Molecular Heterogeneity, Predicts Preoperative Lymph Node Metastasis and Prognosis in Papillary Thyroid CarcinomaRecruitingNCT06241092
- Early-stage Ovarian Clear Cell Carcinoma (OCCC) Patients at Risk of RecurrenceNot yet recruitingNCT06237946
- Neoadjuvant Tislelizumab Plus Chemotherapy for Resectable Locally-advanced Head and Neck Squamous Cell CarcinomaRecruitingNCT06235918Phase 2
- Prospective and Multicenter Italian Registry of Locally Advanced-Metastatic Urothelial CarcinomaRecruitingNCT06235268
- Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPCRecruitingNCT06235203Phase 3
- A Study Evaluating the Efficacy and Safety of ZG005 in Combination With Donafenib or Bevacizumab in Patients With Advanced Hepatocellular CarcinomaNot yet recruitingNCT06233994Not applicable
- Neoadjuvant Adebrelimab With Dalpiciclib for Resectable Esophageal Squamous Cell CarcinomasRecruitingNCT06225921Phase 1
- Safety and Efficacy of TT-00420 Tablets Combined With Toripalimab Injection in Advanced Urological TumorsNot yet recruitingNCT06221774Phase 1/2
- The Added Value of Contrast Enhanced Mammography to Standard Mammography in Assessing the Extent of DCISNot yet recruitingNCT06217458Not applicable
- ctDNA and MRI Parameters in Head and Neck CancerNot yet recruitingNCT06215612Not applicable
- Proteomic Guided First-line Precision Treatment of Renal Clear Cell CarcinomaRecruitingNCT06211790Phase 2
- Study to Evaluate the Efficacy and Safety of Immunotherapy With Axitinib in Advanced Collecting Duct CarcinomaRecruitingNCT06211114Phase 2
- HAIC Combine Tislelizumab and Lenvatinib in the Treatment of HCC With Type IV (Vp4) Portal Vein Tumor Thrombus (HAI-TL)Not yet recruitingNCT06210334Phase 2
- Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal CancerRecruitingNCT06205836Phase 2
- Prognosis of Patients With Upper Tract Urothelial Carcinoma Receiving Kidney-sparing TherapyRecruitingNCT06204406
- Alpha Radiation Emitters Device for the Treatment of Primary and Recurrent Squamous Cell Carcinoma of the Vulva (DaRT).Not yet recruitingNCT06202339Not applicable
- A Study of Diffusing Alpha Radiation Therapy for Patients With Breast Carcinoma in Frail or Elderly Patients.RecruitingNCT06202118Not applicable
- FOLFOX-HAIC Plus Lenvatinib and Toripalimab vs. FOLFOX-HAIC Plus Lenvatinib for Advanced Hepatocellular Carcinoma: a Randomized Controlled and Double-blind TrialRecruitingNCT06201065Phase 3